Circulating biomarkers of iron storage and clearance of incident human papillomavirus infection

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 5, 2012, Pages 859-865

  Siegel, Erin M ^a   Patel, Nitin ^b   Lu, Beibei ^a   Lee, Ji Hyun ^a   Nyitray, Alan G ^a   Huang, Xi ^c   Villa, Luisa L ^d   Franco, Eduardo L ^e   Giuliano, Anna R ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON; TRANSFERRIN RECEPTOR;

ADULT; AGED; ARTICLE; CANCER RISK; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; INFECTION RISK; IRON STORAGE; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; UTERINE CERVIX CANCER; VIRAL CLEARANCE; VIRUS CARCINOGENESIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COHORT STUDIES; FERRITINS; HUMANS; INCIDENCE; IRON; IRON-BINDING PROTEINS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CELL SURFACE; RISK FACTORS; YOUNG ADULT;

EID: 84862867530     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0073     Document Type: Article

References (25)

1. Stevens RG, Jones DY, Micozzi MS, Taylor PR. Body iron stores and the risk of cancer. N Engl J Med 1988;319:1047-52.
2. Huang X. Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal. Mutation Res 2003;533: 153-71. (Pubitemid 37487866)
3. Huang X, Dai J, Fournier J, Ali AM, Zhang Q, Frenkel K. Ferrous ion autoxidation and its chelation in iron-loaded human liver HepG2 cells. Free Radical Biol Med 2002;32:84-92. (Pubitemid 34045140)
4. Palmer HJ, Paulson KE. Reactive oxygen species and antioxidants in signal transduction and gene expression. Nutr Rev 1997;55:353-61. (Pubitemid 27487423)
5. Siegel EM, Salemi JL, Villa LL, Ferenczy A, Franco EL, Giuliano AR. Dietary consumption of antioxidant nutrients and risk of incident cervical intraepithelial neoplasia. Gynecol Oncol 2010;118:289-94.
6. Giuliano A. Cervical carcinogenesis: the role of co-factors and generation of reactive oxygen species. Salud publica de Mexico 2003;45 Suppl 3:S354-60. (Pubitemid 38029652)
7. Garcia-Closas R, Castellsague X, Bosch X, Gonzalez CA. The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence. Int J Cancer 2005;117:629-37. (Pubitemid 41504551)
8. Koulaouzidis A, Said E, Cottier R, Saeed AA. Soluble transferrin receptors and iron deficiency, a step beyond ferritin. A systematic review. J Gastrointestin Liver Dis 2009;18:345-52.
9. Zeleniuch-Jacquotte A, Zhang Q, Dai J, Shore RE, Arslan AA, Koenig KL, et al. Reliability of serum assays of iron status in postmenopausal women. Ann Epidemiol 2007;17:354-8. (Pubitemid 46629029)
10. Ali MA, Akhmedkhanov A, Zeleniuch-Jaquotte A, Toniolo P, Frenkel K, Huang X. Reliability of serum iron, ferritin, nitrite, and association with risk of renal cancer in women. Cancer Detect Prevent 2003;27: 116-21. (Pubitemid 36429590)
11. Franco E, Villa L, Rohan T, Ferenczy A, Petzl-Erler M, Matlashewski G. Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group. Rev Panam Salud Publica 1999;6:223-33. (Pubitemid 29523611)
12. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998;36:3020-7. (Pubitemid 28429431)
13. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens-Part B: biological agents. Lancet Oncol 2009;10:321-2.
14. Zimmermann MB, Hurrell RF. Nutritional iron deficiency. Lancet 2007;370:511-20. (Pubitemid 47214636)
15. Lin DY, Wei LJ. The robust inference for the proportional hazards model. J Am Stat Ass 1989;84:1074-8.
16. Zacharski LR, Ornstein DL, Woloshin S, Schwartz LM. Association of age, sex, and race with body iron stores in adults: analysis of NHANES III data. Am Heart J 2000;140:98-104. (Pubitemid 30471247)
17. Mendes JF, Arruda SF, Siqueira EM, Ito MK, Silva EF. Iron status and oxidative stress biomarkers in adults: a preliminary study. Nutrition 2009;25:379-84.
18. Pynaert I, De Bacquer D, Matthys C, Delanghe J, Temmerman M, De Backer G, et al. Determinants of ferritin and soluble transferrin receptors as iron status parameters in young adult women. Public Health Nutri 2009;12:1775-82.
19. Casabellata G, Di Santolo M, Banfi G, Stel G, Gonano F, Cauci S. Evaluation of iron deficiency in young women in relation to oral contraceptive use. Contraception 2007;76:200-7. (Pubitemid 47248662)
20. Drakesmith H, Prentice A. Viral infection and iron metabolism. Nat Rev Microbiol 2008;6:541-52. (Pubitemid 351863367)
21. Poljak-Blazi M, Jaganjac M, Sabol I, Mihaljevic B, Matovina M, Grce M. Effect of ferric ions on reactive oxygen species formation, cervical cancer cell lines growth and E6/E7 oncogene expression. Toxicol In Vitro 2011;25:160-6.
22. Simonart T, Boelaert JR, Mosselmans R, Andrei G, Noel JC, De Clercq E, et al. Antiproliferative and apoptotic effects of iron chelators on human cervical carcinoma cells. Gynecol Oncol 2002;85:95-102. (Pubitemid 34304016)
23. Pham CG, Bubici C, Zazzeroni F, Papa S, Jones J, Alvarez K, et al. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalphainduced apoptosis by suppressing reactive oxygen species. Cell 2004;119:529-42. (Pubitemid 39482352)
24. Lau AT, Wang Y, Chiu JF. Reactive oxygen species: current knowledge and applications in cancer research and therapeutic. J Cell Biochem 2008;104:657-67. (Pubitemid 351671652)
25. Goetz ME, Luch A. Reactive species: a cell damaging rout assisting to chemical carcinogens. Cancer Lett 2008;266:73-83.